Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lynparza, Bevacizumab Trial Meets Primary Endpoint for Advanced Ovarian Cancer

americanpharmaceuticalreviewAugust 19, 2019

Tag: Bevacizumab , Lynparza , Advanced ovarian cancer

PharmaSources Customer Service